Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Cytotherapy Année : 2021

Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition

Résumé

The International Society for Cell and Gene Therapy mesenchymal stromal cell (MSC) committee has been an interested observer of community interests in all matters related to MSC identity, mechanism of action, potency assessment and etymology, and it has regularly contributed to this conversation through a series of MSC pre-conferences and committee publications dealing with these matters. Arising from these reflections, the authors propose that an overlooked and potentially disruptive perspective is the impact of in vivo persistence on potency that is not predicted by surrogate cellular potency assays performed in vitro and how this translates to in vivo outcomes. Systemic delivery or extravascular implantation at sites removed from the affected organ system seems to be adequate in affecting clinical outcomes in many pre-clinical murine models of acute tissue injury and inflammatory pathology, including the recent European Medicines Agency-approved use of MSCs in Crohn-related fistular disease. The authors further propose that MSC viability and metabolic fitness likely dominate as a potency quality attribute, especially in recipients poised for salutary benefits as defined by emerging predictive biomarkers of response.
Fichier principal
Vignette du fichier
Galipeau_et al_2021_Mesenchymal stroma cell variables_accepted.pdf (1.28 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03229071 , version 1 (15-06-2021)

Identifiants

Citer

Jacques Galipeau, Mauro Krampera, Katarina Leblanc, Jan A Nolta, Donald G Phinney, et al.. Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition. Cytotherapy, 2021, 23 (5), pp.368-372. ⟨10.1016/j.jcyt.2020.11.007⟩. ⟨hal-03229071⟩
187 Consultations
216 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More